dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Naumann, R. Wendel |
dc.contributor.author | Hollebecque, Antoine |
dc.contributor.author | Meyer, Tim |
dc.contributor.author | Devlin, Michael-John |
dc.contributor.author | Oaknin Benzaquen, Ana Mazaltob |
dc.contributor.author | Kerger, Joseph |
dc.date.accessioned | 2021-04-21T07:09:52Z |
dc.date.available | 2021-04-21T07:09:52Z |
dc.date.issued | 2019-11-01 |
dc.identifier.citation | Naumann RW, Hollebecque A, Meyer T, Devlin MJ, Oaknin A, Kerger J, et al. Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: Results from the phase I/II CheckMate 358 trial. J Clin Oncol. 2019 Nov 1;37(31):2825–2834. |
dc.identifier.issn | 1527-7755 |
dc.identifier.uri | https://hdl.handle.net/11351/5884 |
dc.description | Nivolumab; Carcinoma cervical, vaginal o vulvar; Carcinoma metastàtic |
dc.language.iso | eng |
dc.publisher | American Society of Clinical Oncology |
dc.relation.ispartofseries | Journal of Clinical Oncology;37(31) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Aparell genital femení - Càncer |
dc.subject | Medicaments antineoplàstics |
dc.subject.mesh | Genital Neoplasms, Female |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Disease Progression |
dc.title | Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1200/JCO.19.00739 |
dc.subject.decs | neoplasias de los genitales femeninos |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | progresión de la enfermedad |
dc.relation.publishversion | https://ascopubs.org/doi/10.1200/JCO.19.00739 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Naumann RW] Levine Cancer Institute, Atrium Health, Charlotte, NC. [Hollebecque A] Gustave Roussy, Villejuif, France. [Meyer T, Devlin MJ] UCL Cancer Institute, London, United Kingdom. [Oaknin A] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Kerger J] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium |
dc.identifier.pmid | 31487218 |
dc.identifier.wos | 000501780200003 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |